Molecular Gate S.L., new ICMAB-CSIC and BeAble Capital spin-off.

Molecular Gate S.L. aims to become a key player in the anti-counterfeiting industry, particularly in the health sector. The cost-effective security technology developed by the company will ensure the authenticity of pharmaceutical products using smart optical printed elements on the products.